Vitamin B2 (Riboflavin)
Vitamin B2 (Riboflavin) is used in private-label supplement manufacturing. Sourcing, dose anchors and target-market documentation are reviewed per project.
- Type
- Vitamin
- Family
- B-vitamins
- Measured in
- mg
Why brands use Vitamin B2 (Riboflavin)
Vitamin B2 (Riboflavin) is an essential vitamin commonly considered for daily-wellness ranges, sitting in the b-vitamins family. On DAT Supply briefs the positioning is set by the brand brief and reviewed against the target market’s claim rules — we do not pre-position an active for any single benefit. Editorial framing uses only EU 432/2012- or DSHEA-compatible wording — we never promote unauthorised claims, even when the active has consumer-side momentum. Format-wise we have considered Vitamin B2 (Riboflavin) for gummies, powder stick, jelly and strip; the per-format formulation notes below describe the live constraints (taste, payload, stability, packaging) we tune in the formulation pass. Sourcing form (extract ratio for botanicals, salt or chelate form for minerals, free-form vs ester for amino acids) is reviewed against the brief, with documentation matched to the target market’s import rules. Inclusion rate and claim wording are reviewed per project — we don’t publish off-the-shelf doses.
How we use Vitamin B2 (Riboflavin) in formulas
A public-safe formulation reference — how this active behaves in our formats, common pairings and handling notes. Final formulation, dose and on-pack copy are confirmed per project.
- Heat stable
- Limited — use coated forms
- Soluble in matrix
- Conditional
- Vegan supply
- Project-specific
EU-authorised health claims
EU-authorised wording for this ingredient is reviewed per project against Reg. 1924/2006 and the authorised list under Reg. 432/2012. No final claim wording is implied by this page.
Across the EU and UK markets Vitamin B2 (Riboflavin) is treated as a vitamin: any on-pack benefit wording must come from the EU 432/2012 register (UK retains the same wording post-Brexit), and the inclusion rate has to meet the minimum thresholds tied to the chosen claim. For the US market, label benefit copy follows DSHEA structure-function rules with the standard "not intended to diagnose, treat, cure or prevent any disease" disclosure. We never reuse a market’s wording as if it carried over — claim copy is rewritten per market and reviewed per project. Country-level rules (e.g. France, Italy, Belgium for the EU; California Prop 65 for the US) layer on top, and the back-of-pack nutritional table is built against the market’s reference intake framework.
Authorised at ≥15% NRV per daily serving. Claim wording must appear verbatim on consumer packaging. DAT reviews final pack copy per project against EU 1924/2006 and the authorised list under EU 432/2012.